Tilray Inc (NASDAQ:TLRY - Get Free Report)'s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $1.99, but opened at $2.21. Tilray shares last traded at $2.17, with a volume of 19,463,359 shares traded.
Analysts Set New Price Targets
A number of analysts have commented on TLRY shares. Canaccord Genuity Group decreased their target price on Tilray from $4.25 to $4.00 and set a "buy" rating on the stock in a research report on Wednesday, April 10th. Alliance Global Partners increased their price target on shares of Tilray from $2.25 to $2.75 and gave the stock a "neutral" rating in a research note on Friday, April 5th. Finally, CIBC decreased their target price on Tilray from $2.25 to $2.00 and set a "neutral" rating for the company in a report on Wednesday, April 10th.
Get Our Latest Report on TLRY
Tilray Stock Up 5.0 %
The firm has a market capitalization of $1.62 billion, a P/E ratio of -4.75 and a beta of 2.36. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.92 and a quick ratio of 1.18. The firm's fifty day moving average price is $2.01 and its 200-day moving average price is $1.95.
Institutional Trading of Tilray
Several institutional investors and hedge funds have recently bought and sold shares of TLRY. Commonwealth Equity Services LLC grew its stake in shares of Tilray by 10.3% in the 3rd quarter. Commonwealth Equity Services LLC now owns 316,898 shares of the company's stock valued at $757,000 after buying an additional 29,564 shares in the last quarter. TD Asset Management Inc boosted its stake in shares of Tilray by 5.6% in the 3rd quarter. TD Asset Management Inc now owns 1,204,434 shares of the company's stock valued at $2,877,000 after purchasing an additional 64,300 shares in the last quarter. CIBC Asset Management Inc boosted its holdings in shares of Tilray by 19.1% in the 3rd quarter. CIBC Asset Management Inc now owns 648,800 shares of the company's stock worth $1,548,000 after acquiring an additional 104,072 shares in the last quarter. Wealthfront Advisers LLC bought a new stake in shares of Tilray during the third quarter worth $62,000. Finally, Banque Pictet & Cie SA bought a new stake in Tilray during the 3rd quarter worth about $84,000. Institutional investors and hedge funds own 9.35% of the company's stock.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Read More
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
